Literature DB >> 11434709

Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers.

P E Morange1, J F Renucci, M A Charles, M F Aillaud, F Giraud, M Grimaux, I Juhan-Vague.   

Abstract

Free-TFPI (f-TFPI) presents high anticoagulant activity and its plasma level correlates with unfavorable outcomes in unstable angina. Total TFPI (t-TFPI) represents mainly the lipid-bound form which seems to have a poor anticoagulant activity. Until now, it is not known whether the variations of f-TFPI plasma levels are determined by environmental factors. The aim of our study was to evaluate the influence of cardiovascular risk factors on plasma levels of f-TFPI and relations with other endothelial derived molecules in a population of 626 patients (277 men and 349 women) attending a metabolic ward for primary prevention of coronary disease. Free and total TFPI plasma levels were poorly correlated. f-TFPI levels increased with age in both sexes, t-TFPI in women only. Age-adjusted correlations of TFPI levels with conventional cardiovascular risk factors and endothelial cell markers showed different patterns for f-TFPI and t-TFPI. f-TFPI correlated with parameters associated with insulin resistance, particularly in females. f-TFPI was also positively associated in both genders with fibrinogen and endothelial cell markers: t-PA, thrombomodulin (TM) and von Willebrand factor (vWF). t-TFPI correlated strongly with LDL-C in both sexes. It also correlated negatively with parameters of the insulin resistance syndrome. t-TFPI also correlated with TM but not with other endothelial cell markers. The results of the multivariate step by step analysis showed that cardiovascular risk factors poorly explained the f-TFPI variability (7% and 4% in men and women, respectively), whereas they explained 16 and 20% of t-TFPI variability in men and women respectively (mostly related to LDL-C). In conclusion, this study showed that free- and total-TFPI are regulated differently. f-TFPI strongly correlates with endothelial cell markers and t-TFPI is more related to conventional cardiovascular risk factors. The strong gender effect on f-TFPI levels remains to be explained.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434709

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

1.  Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.

Authors:  J Dennis; V Truong; D Aïssi; A Medina-Rivera; S Blankenberg; M Germain; M Lemire; L Antounians; M Civelek; R Schnabel; P Wells; M D Wilson; P-E Morange; D-A Trégouët; F Gagnon
Journal:  J Thromb Haemost       Date:  2016-09-17       Impact factor: 5.824

Review 2.  Endothelial and platelet markers in diabetes mellitus type 2.

Authors:  Peter Kubisz; Lucia Stančiaková; Ján Staško; Peter Galajda; Marián Mokáň
Journal:  World J Diabetes       Date:  2015-04-15

3.  Non-Alcoholic Fatty Liver Disease (NAFLD) - Is it an Emerging Risk Factor for Coronary Artery Disease?: Preliminary study in a local Indian population.

Authors:  Manopriya Thiruvagounder; Shaheen Khan; Dhastagir S Sheriff
Journal:  Sultan Qaboos Univ Med J       Date:  2010-07-19

4.  Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis?

Authors:  Ozgur Harmanci; Yahya Buyukasik; Serafettin Kirazli; Ferhun Balkanci; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

5.  Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes.

Authors:  Trine B Opstad; Alf Age Pettersen; Thomas Weiss; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Thromb J       Date:  2010-05-05

6.  Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.

Authors:  C T Mitchell; A Kamineni; W Palmas; M Cushman
Journal:  Atherosclerosis       Date:  2009-04-24       Impact factor: 5.162

Review 7.  Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.

Authors:  O Asghar; U Alam; S A Hayat; R Aghamohammadzadeh; A M Heagerty; R A Malik
Journal:  Curr Cardiol Rev       Date:  2012-11

8.  Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment.

Authors:  Vibeke Bratseth; Alf-Åge Pettersen; Trine B Opstad; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Thromb J       Date:  2012-08-10

9.  Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes.

Authors:  Sandra Beer; François Feihl; Juan Ruiz; Irène Juhan-Vague; Marie-Françoise Aillaud; Sandrine Golay Wetzel; Lucas Liaudet; Rolf C Gaillard; Bernard Waeber
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Assessment of the relationship between non-alcoholic fatty liver disease and CAD using MSCT.

Authors:  Duran Efe; Fatih Aygün
Journal:  Arq Bras Cardiol       Date:  2013-11-22       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.